Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
EU seeks stronger cooperation with Việt Nam to promote free trade amid global challenges: EC leader 2.
Foreign ministry responds to report on Trump's barring US officials from attending April 30 celebrations 1.